Hypertension Channel
Topics
Medications
Quicklinks
Related Channels

Azilsartan/Chlorthalidone

Azilsartan/chlorthalidone is a drug used to treat high blood pressure. This combination product contains two blood pressure medications -- one that helps relax the blood vessels and another that helps to reduce blood volume. It comes as a tablet that is taken once daily, preferably in the morning because it can increase urination. Possible side effects include dizziness and fatigue.

What Is Azilsartan/Chlorthalidone?

Azilsartan/chlorthalidone (Edarbyclor™) is a prescription medication licensed to treat hypertension, more commonly called high blood pressure. It is a combination of two other prescription medicines: azilsartan (Edarbi®) and chlorthalidone (Thalitone®).
 
(Click What Is Azilsartan/Chlorthalidone Used For? for more information on this topic, including possible off-label uses.)
 

Are There Side Effects?

Just like any medicine, azilsartan/chlorthalidone may cause side effects. However, not everyone who takes the drug will experience problems. In fact, most people tolerate it quite well.
 
If reactions do occur, in most cases, they are minor and either require no treatment or are treated easily by you or your healthcare provider. Serious side effects are less common.
 
Common side effects of azilsartan/chlorthalidone include but are not limited to:
 
  • Dizziness
  • Fatigue.
 
(Click Azilsartan/Chlorthalidone Side Effects to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)
 
Ouch! 6 Types of Pain You Might Experience When Getting a Stent

Azilsartan/Chlorthalidone Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.